GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Total Current Assets

Livzon Pharmaceutical Group (HKSE:01513) Total Current Assets : HK$18,292 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Livzon Pharmaceutical Group Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Livzon Pharmaceutical Group's total current assets for the quarter that ended in Sep. 2024 was HK$18,292 Mil.

Livzon Pharmaceutical Group Total Current Assets Historical Data

The historical data trend for Livzon Pharmaceutical Group's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Total Current Assets Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,324.67 17,339.75 17,966.73 18,969.97 18,885.38

Livzon Pharmaceutical Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,219.26 18,885.38 18,660.73 18,846.81 18,292.11

Livzon Pharmaceutical Group Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Livzon Pharmaceutical Group's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=12477.3+3945.26+2253.897+208.921
=18,885

Livzon Pharmaceutical Group's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=11901.378+3827.432+2190.449+372.848
=18,292

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Livzon Pharmaceutical Group  (HKSE:01513) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Livzon Pharmaceutical Group's Liquidation Value for the quarter that ended in Sep. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=11901.378-10981.3+0.75 * 2363.752+0.5 * 2190.449
=3,788

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Livzon Pharmaceutical Group Total Current Assets Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Total Current Assets
Comparable Companies
SHSE:600518 SZSE:002603 SHSE:600566 SZSE:002262 SHSE:600521 SHSE:600079 SZSE:000423 SZSE:300142 SHSE:603707 SZSE:000623 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
LVZPF:USA 000513:China
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Website
https://www.livzon.com.cn
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in PRC which is pharmaceutical manufacturing.
Executives
Zhu Baoguo 2201 Interest of corporation controlled by you

Livzon Pharmaceutical Group Headlines

No Headlines